ISN-ISPD Joint webinar: PD for COVID-19-associated AKI: questions and updates on clinical experience

ISN-ISPD Joint webinar: PD for COVID-19-associated AKI: questions and updates on clinical experience

Publication date: Dec 12, 2025

Um there’s a number of issues around um uh um uh things like recovery residual kidney function. um one recovered renal function um quite um within a few days um and the other one has now been converted to CBHD. Um just before I start introducing uh the panel um can I just uh please um remind you to ask questions. um uh um uh and I will keep an eye on those and put them to the panel as we go through our structured uh discussion. um selecting the patients to avoid people who needed proning, avoiding people who are really catabolic with severe hypercalemia um or volume overload or people with um abdominal surgery. Um but uh um uh the questions I want us to deal with first of all really is what is the role of PD in this situation? Um, uh um the So again at Kings, this was responding to an emergency um initially with CVBH machines and then ultimately with the consumables and things.

Concepts Keywords
Biochemistry Acute
Desperation Aki
Hemodialysis Bit
Lsu Catheterss
Weekly Covid
Experience
Fluid
Itu
Kidney
Lot
Nurses
Patient
Patients
Questions
Team

Semantics

Type Source Name
disease MESH COVID-19
disease MESH infection
disease MESH acute kidney injury
drug DRUGBANK L-Asparagine
disease MESH injury
drug DRUGBANK Hexachlorophene
disease MESH peritonitis
drug DRUGBANK Dextrose unspecified form
drug DRUGBANK Pearl (hyriopsis cumingii)
drug DRUGBANK Nonoxynol-9
disease MESH obesity
drug DRUGBANK Medical air
drug DRUGBANK Creatine
disease MESH QPD
drug DRUGBANK Water
drug DRUGBANK Icodextrin
disease MESH lad
disease MESH uremia
disease MESH plan
drug DRUGBANK Ranitidine
drug DRUGBANK Creatinine
disease MESH emergency
drug DRUGBANK Etoperidone
drug DRUGBANK Coenzyme M
drug DRUGBANK Isoxaflutole
disease MESH infectious diseases
disease MESH anxiety
disease MESH SLE
drug DRUGBANK Tropicamide

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *